HealthMore in Health→
FDA Tests a New Regulatory Model With Real-Time Clinical Trial Data
Key Takeaways
- The FDA is launching a pilot to collect and review clinical trial data in real time.
- AstraZeneca and Amgen are the first companies participating in the program.
- The effort could shift regulatory review toward earlier and more continuous oversight of ongoing studies.
DE
DT Editorial Team··via endpoints.news
